Prevalence and Antibiotic Resistance Profiles of Uropathogens in Haldia, an Industrial City in Eastern India
DOI:
https://doi.org/10.37506/6g84cj73Abstract
Background: A significant health concern in the community with the highest morbidity is urinary tract infection
(UTI). Moreover, age, comorbidity and bacterial drug-resistance worsen the situation. Changes in ecological and
host factors plus misuse of drugs promote bacterial uropathogens becoming antibiotic-resistant.
Objectives: Presently, we evaluate UTI prevalence and causative bacterial antibiotic-resistance-patterns in an
industrial-town with educational-hub situated in eastern part of India. Age- and gender- wise comparison of
bacterial susceptibility-resistance was performed.
Materials and methods: A total 83 individuals (23 males and 60 females)from the city hospital and local
pathological-centers provided urine samples maintaining proper norms. Routine microbiological/pathological
tests and detailed drug-resistance screening were performed.
Results: The major infecting organisms E. coli, K. pneumoniae and P. aeruginosa are prevalent with approximately
25:6:1 ratio in all age groups. But age wise,60% of >31 years group is infected by E. coli the rest two groups; 31-60
and >60 years are infected ~80% by E. coli. When compared to the WHO data, E.coli infection is more in the studied
area (78% vs 67%). Genderwise, female is more affected by E. coli andmale is more affected by P. aeruginosa.
Conclusions: Among patient-derived bacterial isolates, only 35.17% of antibiotics were effective against E. coli,
and 23.66% were effective for Klebsiella sp. indicating a high level of resistance. In summary, E. Coli is resistant to
the majority of medications. Nitrofurantoin and amikacin are found to be the most sensitive to the uropathogens
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Biswajit Chakraborti, Ramsundar Kamilya, Sanchari Basu, Sourav Pradhan, Sourav Biswas, Pikash Pratim Maity, Debabrata Adak, Nirmalya K. Sinha, Smarajit Maiti

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.